What is the comparative effectiveness of serial dilatation versus Per Oral Endoscopic Myotomy (POEM) for treating achalasia in patients with varying medical histories and comorbid conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

POEM vs Serial Pneumatic Dilation for Achalasia

POEM is superior to serial pneumatic dilation for treatment-naive achalasia patients, achieving 92% treatment success at 2 years compared to 54% with pneumatic dilation, though patients must accept a significantly higher risk of reflux esophagitis (41% vs 7%). 1

Primary Treatment Recommendation

For treatment-naive patients with Type I or Type II achalasia, POEM should be considered the preferred initial treatment over pneumatic dilation when performed at high-volume centers by experienced operators, with mandatory counseling about post-procedure reflux management. 1, 2

Supporting Evidence for POEM Superiority

  • The highest quality randomized trial (2019, JAMA) demonstrated POEM achieved 92% treatment success versus 54% for pneumatic dilation at 2-year follow-up, representing a 38% absolute difference (95% CI: 22%-52%, P<0.001) 1
  • A 2024 SAGES guideline update issued a conditional recommendation favoring POEM over pneumatic dilation based on this superior efficacy 2
  • Multiple uncontrolled series with 100-500 patients show POEM success rates of 89-97% at follow-up periods of 11-36 months 3

Treatment Selection Algorithm by Achalasia Subtype

Type III Achalasia (Spastic)

POEM is the definitive first-line treatment for Type III achalasia, with myotomy length calibrated to the spastic segment on high-resolution manometry or thickened segment on endoscopic ultrasound. 3, 4, 2

  • Type III has the poorest response to all conventional treatments including pneumatic dilation 5
  • POEM allows longer myotomy tailored to the spastic segment, which is not achievable with pneumatic dilation 3, 4

Type I and Type II Achalasia

Either POEM with appropriate proton pump inhibitor use or laparoscopic Heller myotomy with fundoplication are acceptable first-line options, but POEM demonstrates superior efficacy compared to pneumatic dilation. 3, 6, 2

  • Traditional guidelines recommended pneumatic dilation and laparoscopic Heller myotomy as first-line treatments with equivalent 5-year outcomes, noting pneumatic dilation has less morbidity and cost 3
  • However, the 2019 randomized trial definitively showed POEM superiority over pneumatic dilation 1
  • Pneumatic dilation requires anticipation of repeat dilations over years 3

Critical Reflux Considerations

Post-POEM Reflux Burden

Reflux esophagitis occurs in 41-57% of POEM patients compared to 7-20% after pneumatic dilation, with 23-44% developing endoscopic esophagitis requiring surveillance. 3, 7, 1

  • At 3 months post-POEM, 57% had reflux esophagitis versus 20% after laparoscopic Heller myotomy; at 24 months, rates were 44% versus 29% 7
  • In the POEM vs pneumatic dilation trial, reflux esophagitis occurred in 41% of POEM patients versus 7% of pneumatic dilation patients at 2 years 1
  • Multicenter data showed 58% of POEM patients had pH-metry or endoscopic evidence of reflux, with 23% having endoscopic esophagitis 3

Mandatory Patient Counseling

Before POEM, patients must be explicitly counseled about the high probability of requiring indefinite proton pump inhibitor therapy and surveillance endoscopy for asymptomatic erosive esophagitis or Barrett's esophagus. 3, 6, 4

  • 31% of patients with good clinical outcomes and no initial esophagitis developed erosive disease at mean 29-month follow-up, including 2 cases of new Barrett's esophagus 3
  • Many patients with erosive esophagitis remain asymptomatic, necessitating surveillance endoscopy 3

Procedural Volume Requirements

POEM should only be performed by experienced physicians in high-volume centers, as 20-40 procedures are required to achieve competence and 60 for mastery. 3, 6, 4

Management of Failed POEM

If POEM fails, repeat POEM or laparoscopic Heller myotomy show modest efficacy (63% and 45% respectively), while pneumatic dilation after failed POEM has poor efficacy of only 0-20%. 8

  • Among 441 POEM patients, 9.8% developed persistent or recurrent symptoms (Eckardt score >3) within 3 years 8
  • Pneumatic dilation is ineffective as salvage therapy after POEM failure 8
  • Male patients have higher retreatment failure rates 8

Situations Favoring Pneumatic Dilation

Despite POEM's superior efficacy, pneumatic dilation may be preferred when:

  • High-volume POEM expertise is unavailable 3, 6
  • Patient cannot accept 40-57% risk of reflux esophagitis 7, 1
  • Significant cost constraints exist, as pneumatic dilation has lower cost 3
  • Patient has hiatal hernia, as POEM shows higher reflux risk in this population 3

Insufficient Data Scenarios

There is insufficient evidence for POEM efficacy in advanced esophageal dilation, sigmoidization, epiphrenic diverticulum, and hiatal hernia. 3, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Per-Oral Endoscopic Myotomy (POEM) Treatment Approach for Achalasia and Swallowing Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Achalasia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

POEM for Type 1 Achalasia: Efficacy and Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia.

The New England journal of medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.